Clinical Trial: A Study to Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777848) titled 'A Study to Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).' on Aug. 17.

Brief Summary: This is a randomized, controlled, multicenter clinical study to evaluate the efficacy and safety of RAG-01 monotherapy and in combination with chemotherapy in patients with NMIBC.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Non-muscle Invasive Bladder Cancer (NMIBC)

Intervention: DRUG: RAG-01

The RAG-01 will be administered as a single agent for evaluation the efficiency in intermediate-risk NMIBC patients.

DR...